-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, MZDRYskwCYDcKvSHVTCbM2aUpB0MFea7OOFhibDwF2U+lOp6A1vS+zfJ1Cp5x4se TdcZeNP7fU8EuURGm+YqKQ== 0000936392-99-000301.txt : 19990325 0000936392-99-000301.hdr.sgml : 19990325 ACCESSION NUMBER: 0000936392-99-000301 CONFORMED SUBMISSION TYPE: 424B3 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19990323 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HOLLIS EDEN PHARMACEUTICALS INC /DE/ CENTRAL INDEX KEY: 0000899394 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133697002 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: SEC FILE NUMBER: 333-69725 FILM NUMBER: 99570561 BUSINESS ADDRESS: STREET 1: 9333 GENESEE AVENUE STREET 2: SUITE 110 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 6195879333 MAIL ADDRESS: STREET 1: 9333 GENESEE AVENUE STREET 2: SUITE 110 CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: INITIAL ACQUISITION CORP DATE OF NAME CHANGE: 19930329 424B3 1 PROSPECTUS SUPPLEMENT 1 This filing is made pursuant to Rule 424(b)(3) under the Securities Act of 1933 in connection with Registration No. 333-69725 SUPPLEMENT TO PROSPECTUS DATED JANUARY 8, 1999 931,373 SHARES HOLLIS-EDEN PHARMACEUTICALS, INC. COMMON STOCK ------------------------- The Prospectus dated January 8, 1999 is hereby supplemented as follows to restate, in its entirety, the "Selling Stockholders" section on page 11 of the Prospectus: SELLING STOCKHOLDERS The following table sets forth the names of the Selling Stockholders and the number of shares of Common Stock owned beneficially by them as of March 17, 1999 which may be offered pursuant to this Prospectus. This information is based upon information provided by each selling stockholder. Because the Selling Stockholders may offer all, some or none of their respective shares of Common Stock, no definitive estimate as to the number of shares thereof that will be held by the Selling Stockholders after such offering can be provided. The term "Selling Stockholder" includes the holders listed below and their transferees, pledgees, donees or other successors.
SHARES BEING NAME OFFERED(1) ---- ------------ MDB Capital................................................ 316,981 LHIP Acquisition Company................................... 135,849 International Investor Relations Group..................... 3,493 Boniface Costa............................................. 22,222 Growth Ventures, Inc. Pension Plan and Trust............... 189,938 Inverness Investments Profit Sharing Plan.................. 99,999 Leonard Rothstein.......................................... 49,999 Jodi Rothstein............................................. 50,000 B. A. Bates................................................ 20,964 Underwood Family Partners.................................. 20,964 Brennan, Key & Bromberg, P.C. ............................. 20,964 ------- Total............................................ 931,373 =======
- ------------------------- (1) Includes 927,880 shares of common stock issuable upon the exercise of certain warrants. None of the selling stockholders has, or within the past three years has had, any position, office or other material relationship with Hollis-Eden or any of its predecessors or affiliates. The date of this Prospectus Supplement is March 23, 1999. -----END PRIVACY-ENHANCED MESSAGE-----